Vulnerability Description
OpenClaw before 2026.4.2 contains an approval integrity vulnerability in pnpm dlx that fails to bind local script operands consistently with pnpm exec flows. Attackers can replace approved local scripts before execution without invalidating the approval plan, allowing execution of modified script contents.
CVSS Score
MEDIUM
Affected Products
| Vendor | Product | Versions |
|---|---|---|
| Openclaw | Openclaw | < 2026.4.2 |
Related Weaknesses (CWE)
References
- https://github.com/openclaw/openclaw/commit/176c059b05357df1bc09d4328a2380670859Patch
- https://github.com/openclaw/openclaw/security/advisories/GHSA-w6wx-jq6j-6mcjVendor Advisory
- https://www.vulncheck.com/advisories/openclaw-approval-integrity-bypass-in-pnpm-Third Party Advisory
FAQ
What is CVE-2026-41360?
CVE-2026-41360 is a vulnerability with a CVSS score of 6.7 (MEDIUM). OpenClaw before 2026.4.2 contains an approval integrity vulnerability in pnpm dlx that fails to bind local script operands consistently with pnpm exec flows. Attackers can replace approved local scrip...
How severe is CVE-2026-41360?
CVE-2026-41360 has been rated MEDIUM with a CVSS base score of 6.7/10. Review the CVSS metrics above for detailed severity breakdown.
Is there a patch for CVE-2026-41360?
Check the references section above for vendor advisories and patch information. Affected products include: Openclaw Openclaw.